June 3, 2019 “If advanced urothelial cancer progresses following treatment with platinum-based chemotherapy and immunotherapy with checkpoint inhibitors there are no FDA approved treatment options. Although this is a small, phase II trial, the anti-tumor activity demonstrated in patients whose disease progressed on chemotherapy and immunotherapy is promising, we await larger studies to confirm these...
Pro zobrazení tohoto obsahu je třeba být přihlášen.